Why are commercial plans lagging Medicare on site-neutral drug payments?

Medicare finalized site-neutral payment for drug administration in certain off-campus hospital outpatient departments starting Jan. 1, 2026, with CMS projecting $290 million in 2026 savings. The article argues commercial plans have been slower to adopt site-of-care programs despite evidence that hospital outpatient infusions cost more without better outcomes.